Biofunctional organic nanocrystals for quantitative detection of pathogen deoxyribonucleic acid

Analytica Chimica Acta

Volumn 584, Issue 1, 2007, Pages 7-11

  Chan, Cangel Pui yee ^a   Tzang, Lawrence Chi hung ^b   Sin, King keung ^a   Ji, Sheng lin ^b   Cheung, Kwan yee ^c   Tam, Tze kin ^a   Yang, Michael Meng su ^b   Renneberg, Reinhard ^a   Seydack, Matthias ^d  

^a HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Hong Kong)

^b CITY UNIVERSITY OF HONG KONG   (Hong Kong)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^d 8sensbiognostic AG   (Germany)

Author keywords

Fluorescein 5 isothiocyanate; Fluorescein diacetate; Horseradish peroxidase; Human papillomavirus

Indexed keywords

COLLOIDS; DIAGNOSIS; DNA; NANOTECHNOLOGY; SURFACE ACTIVE AGENTS; VIRUSES;

BIOFUNCTIONAL ORGANIC NANOCRYSTALS; FLUORESCEIN 5-ISOTHIOCYANATE; FLUORESCEIN DIACETATE; HORSERADISH PEROXIDASE; HUMAN PAPILLOMAVIRUS;

NANOSTRUCTURED MATERIALS;

FLUORESCEIN DIACETATE; FLUORESCEIN ISOTHIOCYANATE; HORSERADISH PEROXIDASE; NANOCRYSTAL; POLYMER; PRIMER DNA; STREPTAVIDIN; SURFACTANT; VIRUS DNA;

ARTICLE; BIOTINYLATION; DISSOLUTION; DNA DETERMINATION; FLUORESCENCE; NANOTECHNOLOGY; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; QUANTITATIVE ASSAY; VIRUS DETECTION; WART VIRUS;

ADSORPTION; ALPHAPAPILLOMAVIRUS; BIOTINYLATION; DNA, VIRAL; GENE AMPLIFICATION; GENOTYPE; HUMANS; NANOPARTICLES; NUCLEIC ACID HYBRIDIZATION; SENSITIVITY AND SPECIFICITY;

ARMORACIA RUSTICANA; HUMAN PAPILLOMAVIRUS;

EID: 33846461165     PISSN: 00032670     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.aca.2006.11.025     Document Type: Article

References (24)

1. Burd E.M. Clin. Microbiol. Rev. 16 (2003) 1-17
2. Bosch F.X., Manos M.M., Munoz N., Sherman M., Jansen A.M., Peto J., Schiffman M.H., Moreno V., Kurman R., and Shah K.V. J. Natl. Cancer Inst. 87 (1995) 769-802
3. Bosch F.X., Munoz N., Shah K.V., and Menheus A. Int. J. Cancer 52 (1992) 171-173
4. Kulmala S.M., et al., The NIS Corhort Study Group. J. Clin. Microbiol. 42 (2004) 2470-2475
5. WHO. 2006, available at: http://www.who.int/vaccine_research/diseases/viral_cancers/en/index3.htm l.
6. Wright J.D., and Herzong T.J. Curr. Womens Health Rep. 2 (2002) 259-265
7. Lo J.Y.C. H. K. Dermatol. Venereol. Bull. 11 (2003) 9-14
8. Brentjens M.H., Yeung-Yue K.A., Lee P.C., and Tyring S.K. Dermatol. Clin. 20 (2002) 315-331
9. Bekkers R.L., Massuger L.F., Bulten J., and Melchers W.J. Rev. Med. Virol. 14 (2004) 95-105
10. Ngan H.Y., Collins R.J., Wong K.Y., Cheung A., Lai C.F., and Liu Y.T. Int. J. Gynecol. Obstet. 41 (1993) 75-79
11. Franco F.L. J. Natl. Cancer Inst. Monogr. 31 (2003) 89-96
12. Kulmala S.M., Syrjanen S., and Shabalova I. J. Clin. Microbiol. 42 (2004) 2470-2475
13. Clifford G.M., Smith J.S., Plummer M., Munoz N., and Franceschi S. Br. J. Cancer 88 (2003) 63-73
14. Smith J.S., Herrero R., Bosetti C., Munoz N., Bosch F.X., Eluf-Neto J., Meijer X., Castellsague C.J.L.M., Van den B., Adriaan J.C., Franceschi S., and Ashley R. J. Natl. Cancer Inst. 94 (2002) 1604-1613
15. Seydack M. Biosens. Bioelectron. 20 (2005) 2454-2469
16. Alivisatos P. Nat. Biotechnol. 22 (2004) 47-52
17. Penn S.G., He L., and Natan M.J. Curr. Opin. Chem. Biol. 7 (2003) 607-615
18. Trau D., Yang W., Seydack M., Caruso F., Yu N.T., and Renneberg R. Anal. Chem. 74 (2002) 5480-5486
19. Chan C.P., Bruemmel Y., Seydack M., Sin K.K., Wong L.W., Merisko-Liversidge E., Trau D., and Renneberg R. Anal. Chem. 76 (2004) 3638-3645
20. Sin K.K., Chan C.P., Pang T.T., Seydack M., and Renneberg R. Anal. Bioanal. Chem. 384 (2006) 638-644
21. Sin K.K., Chan C.P., Leung W.M., Seydack M., and Renneberg R. IEE Proc. Nanobiotechnol. 153 (2006) 54-58
22. Gravitt P.E., Peyton C.L., Alessi T.Q., Wheeler C.M., Coutlee F., Hildesheim A., Schiffman M.H., Scott D.R., and Apple R.J. J. Clin. Microbiol. 38 (2000) 357-361
23. Gravitt P.E., Peyton C.L., Apple R.J., and Wheeler C.M. J. Clin. Microbiol. 36 (1998) 3020-3027
24. sBosch™ Tech Note, vol. 5, No. 37. 2000.